(Q33906007)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10795402%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Towards cannabinoid drugs--revisited (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10795402%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

1

R Mechoulam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10795402%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

L Hanus

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10795402%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E Fride

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10795402%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10795402%20AND%20SRC:MED&resulttype=core&format=json

Progress in medicinal chemistry

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10795402%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10795402%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

199-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10795402%20AND%20SRC:MED&resulttype=core&format=json

5 Towards cannabinoid drugs

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Federal foolishness and marijuana

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Search for endogenous ligands of the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Pharmacology of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cannabinoid receptor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Pharmacology of marijuana

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

A novel probe for the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Effects of anandamide on cannabinoid receptors in rat brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

An endogenous cannabinoid as an endothelium-derived vasorelaxant

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cannabinoid ligand-receptor signaling in the mouse uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Short and long-term effects of pre-natal cannabis inhalation upon rat offspring

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Developmental aspects of anandamide: ontogeny of response and prenatal exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Pharmacological and behavioral evaluation of alkylated anandamide analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

A rational search for the separation of psychoactivity and analgesia in cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

The design, synthesis and testing of desoxy-CBD: further evidence for a region of steric interference at the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

C-Attached aminoalkylindoles: potent cannabinoid mimetics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

AM630, a competitive cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

(Aminoalkyl)indole isothiocyanates as potential electrophilic affinity ligands for the brain cannabinoid receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Recent clinical experience with dronabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

An efficient new cannabinoid antiemetic in pediatric oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Drug treatment of chemotherapy-induced delayed emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Effect of dronabinol on nutritional status in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cannabinoids and appetite stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Neuronal responses to delta 9-tetrahydrocannabinol in the solitary tract nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Suppression of experimental autoimmune encephalomyelitis by cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

(+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

The perceived effects of smoked cannabis on patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Tetrahydrocannabinol for tremor in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Effect of cannabinoids on spasticity and ataxia in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Nabilone in the treatment of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Effect of combination of drugs with acupuncture on analgesic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Selective encoding and retrieval of affective words during exposure to aversive stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cannabinoids: the separation of central from peripheral effects on a structural basis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

1 reference

7 January 2021

A cannabinoid with cardiovascular activity but no overt behavioral effects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

New antihypertensive cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Mechanism of the hypotensive action of anandamide in anesthetized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Central nervous system and peripheral mechanisms in ocular hypotensive effect of cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Effects of topical anandamides on intraocular pressure in normotensive rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Enhancement by alpha-fluoromethylhistidine of the thiopental sleep-prolonging action of delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Chemical characterization of a family of brain lipids that induce sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Anandamide may mediate sleep induction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Antianxiety effect of cannabidiol in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Chemical basis of hashish activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Implications of the Copernican principle for our future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates receptor-mediated neurotoxicity in primary cultures of rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

HU-211, a non-psychotropic cannabinoid, rescues cortical neurones from excitatory amino acid toxicity in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

A novel nonpsychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Derivatives of Dexanabinol. I. Water-soluble salts of glycinate esters

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Derivatives of dexanabinol. II. Salts of amino acid esters containing tertiary and quaternary heterocyclic nitrogen with increased water-solubility

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-delta 6- tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

Development of HU-211 as a neuroprotectant for ischemic brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970037-7

7 January 2021

10.1016/S0079-6468(08)70037-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10795402%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference